The Maryland Affiliate of Susan G. Komen for the Cure® has awarded a two-year $150,000 grant to Dr. Edward Sausville to help increase access to breast cancer clinical trials for women in Maryland.
The Komen grant will support an initiative at the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) to increase access to and enrollment on federally funded breast cancer trials, with a specific focus on the underserved minority population.
The program will involve a dedicated clinical research team whose focus will be to understand and work to meet the needs of the participants who enroll in breast cancer clinical trials. In addition to providing access to cutting-edge clinical trials, the research team will explore the day-to-day, life-changing impact cancer diagnosis and treatment can have on a breast cancer patient.
“Komen for the Cure is a vital partner in the clinical research mission of the UMGCC’s efforts to help women with all stages of breast cancer. Their support will play a critical role in the extension of clinical trial opportunities to all of Maryland’s citizens,” said Dr. Sausville.
Komen Affiliates fund innovative programs that help women and men overcome the cultural, social, educational and financial barriers to breast cancer screening and treatment. “We are confident that through the work of each of these programs, women who would not have otherwise had access to mammograms will be screened and women undergoing treatment, as well as their families, will receive medical care, support and access to cutting edge clinical trials,” said Robin Prothro, Komen Maryland executive director.
For information about the programs and services of the University of Maryland Greenebaum Cancer Center, or about clinical trials for breast cancer or other types of cancer, please call 1-800-888-8823.